Pomerantz LLP Announces Class Action Lawsuit Against Reckitt Benckiser Group Plc

Strategic Insights -

Pomerantz LLP, a renowned law firm specializing in corporate, securities, and antitrust class litigation, has filed a class action lawsuit against Reckitt Benckiser Group Plc (RBGLY). The lawsuit concerns allegations of securities fraud and other unlawful business practices by Reckitt and its officers and directors. The class action seeks to represent all individuals who purchased or otherwise acquired Reckitt securities during the Class Period.

As a result of the Illinois jury's $60 million verdict against Reckitt's Mead Johnson subsidiary in March 2024, Reckitt's American Depositary Share (ADS) price fell by $1.87 per share, or nearly 14%. Then, in July 2024, a Missouri jury awarded $495 million against Abbott Laboratories, Inc. in a similar lawsuit, leading to Reckitt's ADS price decreasing by $1.02 per share, or nearly 9%. Pomerantz LLP has a long history of fighting for the rights of victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members.

Key Takeaways:

  • The class action lawsuit has been filed against Reckitt Benckiser Group Plc (RBGLY) by Pomerantz LLP.
  • The lawsuit concerns allegations of securities fraud and other unlawful business practices by Reckitt and its officers and directors.
  • The class action seeks to represent all individuals who purchased or otherwise acquired Reckitt securities during the Class Period.
  • The class action deadline is August 4, 2025, to ask the Court to appoint you as Lead Plaintiff for the class.
  • A copy of the Complaint can be obtained at .
  • In March 2024, an Illinois jury returned a $60 million verdict in a lawsuit against Reckitt's Mead Johnson subsidiary.
  • The jury specifically found that Mead Johnson was negligent in failing to warn that consuming Mead Johnson's cow's milk-based formula increased the risk of necrotizing enterocolitis (NEC) in preterm infants.
  • On this news, Reckitt's American Depositary Share (ADS) price fell $1.87 per share, or nearly 14%, to close at $11.44 per share on March 15, 2024.
  • In July 2024, a Missouri jury awarded $495 million against Abbott Laboratories, Inc. in a similar lawsuit.
  • The Missouri jury also made similar findings regarding Abbott's specialized baby formula and the risk of NEC.
  • On this news, Reckitt's ADS price fell $1.02 per share, or nearly 9%, to close at $10.64 per share on July 29, 2024.
  • Pomerantz LLP has a long history of fighting for the rights of victims of securities fraud, breaches of fiduciary duty, and corporate misconduct.
  • The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members.

Statistics:

  • The class action lawsuit was filed by Pomerantz LLP on July 7, 2025.
  • The lawsuit concerns the period from March 15, 2024, to July 29, 2024.
  • The class action seeks to represent all individuals who purchased or otherwise acquired Reckitt securities during the Class Period.
  • The class action deadline is August 4, 2025, to ask the Court to appoint you as Lead Plaintiff for the class.
  • In March 2024, an Illinois jury returned a $60 million verdict in a lawsuit against Reckitt's Mead Johnson subsidiary.
  • The jury specifically found that Mead Johnson was negligent in failing to warn that consuming Mead Johnson's cow's milk-based formula increased the risk of NEC in preterm infants.
  • On this news, Reckitt's American Depositary Share (ADS) price fell $1.87 per share, or nearly 14%, to close at $11.44 per share on March 15, 2024.
  • In July 2024, a Missouri jury awarded $495 million against Abbott Laboratories, Inc. in a similar lawsuit.
  • The Missouri jury also made similar findings regarding Abbott's specialized baby formula and the risk of NEC.
  • On this news, Reckitt's ADS price fell $1.02 per share, or nearly 9%, to close at $10.64 per share on July 29, 2024.

Sources:

  • "Pomerantz LLP Announces the Filing of a Class Action against Reckitt Benckiser Group Plc." Pomerantz LLP, July 7, 2025.
  • Pomerantz LLP. "Pomerantz LLP Files Class Action against Reckitt Benckiser Group Plc." PRNewswire, July 7, 2025.